New heart attack drug strategy aims to cut bleeding risks
NCT ID NCT04755387
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to use blood thinners after a heart attack. The goal is to lower the risk of serious bleeding while still preventing another heart attack or stroke. About 2,300 adults who had a heart attack and received a stent will take part. Half will get a reduced dose of ticagrelor and stop aspirin early, while the other half will follow the standard treatment plan.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
DongA University Hospital
RECRUITINGBusan, 602-715, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which strategy wins for heart attack patients with multiple blocked arteries?
- Can a Plant-Based diet calm the immune system after a heart attack?
- Can a quick shot stop a heart attack in its tracks?
- A sharper eye on the heart: new blood test aims to spot heart attacks faster
- Can a Stick-On AI patch replace wires for heart monitoring after surgery?
- A digital coach for the heart: app aims to keep risk factors in check after a heart attack